Ms Prithi Raguraman is currently a PhD Scholar at the Center for Molecular Medicine and Innovative Therapeutics, Murdoch University in Perth, Australia. Before joining Murdoch University, she completed her Bachelor's of Technology in Biotechnology degree from SRM University in India, and earned her Master's from Trinity College Dublin in Ireland. Her current research is focused on developing RNA-targeting therapies for cancers.